journal article·2025-04Open access

Computational exploration of the self-aggregation mechanisms of phenol-soluble modulins β1 and β2 in Staphylococcus aureus biofilms

Huan Xu, Xiaohan Zhang, Zhongyue Lv, Fengjuan Huang, Yu Zou, Chuang Wang, Feng Ding, Yunxiang Sun

Abstract

The formation of functional bacterial amyloids by phenol-soluble modulins (PSMs) in Staphylococcus aureus is a critical component of biofilm-associated infections, providing robust protective barriers against antimicrobial agents and immune defenses. Clarifying the molecular mechanisms of PSM self-assembly within the biofilm matrix is essential for developing strategies to disrupt biofilm integrity and combat biofilm-related infections. In this study, we analyzed the self-assembly dynamics of PSM-β1 and PSM-β2 by examining their folding and dimerization through long-timescale atomistic discrete molecular dynamics simulations. Our findings revealed that both peptides primarily adopt helical structures as monomers but shift to β-sheets upon dimerization. Monomeric state, PSM-β1 exhibited frequent transitions between helical and β-sheet forms, while PSM-β2 largely retained a helical structure. Upon dimerization, both peptides showed pronounced β-sheet formation around conserved C-terminal residues 21-44. Residues 21-33, largely unstructured as monomers, demonstrated strong tendencies for β-sheet formation and intermolecular interactions, underscoring their central role in the self-assembly of both peptides. Additionally, the PSM-β1 N-terminus formed β-sheets only when interacting with the C-terminus, whereas the PSM-β2 N-terminus remained helical and uninvolved in β-sheet formation. These distinct aggregation behaviors likely contribute to biofilm dynamics, with C-terminal regions facilitating biofilm formation and N-terminal regions influencing stability. Targeting residues 21-33 in PSM-β1 and PSM-β2 offers a promising therapeutic approach for disrupting biofilm integrity. This study advances our understanding of PSM-β1 and PSM-β2 self-assembly and presents new targets for drug design against biofilm-associated diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bacterial biofilms and quorum sensing · Biochemical and Structural Characterization · Bacterial Genetics and Biotechnology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (70)

Show source-provided references
1. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules10.1126/science.1173155 ↗
2. Functional amyloids in the human body10.1016/j.bmcl.2021.127914 ↗
3. Half a century of amyloids: past, present and future10.1039/C9CS00199A ↗
4. A new era for understanding amyloid structures and disease10.1038/s41580-018-0060-8 ↗
5. Implications of peptide assemblies in amyloid diseases10.1039/C7CS00372B ↗
6. Amyloid oligomers: a joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis10.1021/acs.chemrev.0c01122 ↗
7. Protein-based biological materials: molecular design and artificial production10.1021/acs.chemrev.2c00621 ↗
8. Protein based biomaterials for therapeutic and diagnostic applications
9. Thermo- and pH-responsive fibrillization of squid suckerin A1H1 peptide10.1039/C9NR09271D ↗
10. Spontaneous formation of beta-sheet nano-barrels during the early aggregation of Alzheimer's amyloid beta10.1016/j.nantod.2021.101125 ↗
11. Misfolding and self-assembly dynamics of microtubule-binding repeats of the Alzheimer-related protein tau10.1021/acs.jcim.1c00217 ↗
12. Molecular insights into the misfolding and dimerization dynamics of the full-length alpha-synuclein from atomistic discrete molecular dynamics simulations10.1021/acschemneuro.2c00531 ↗
13. Small soluble alpha-synuclein aggregates are the toxic species in Parkinson's disease10.1038/s41467-022-33252-6 ↗
14. Amyloid self-assembly of hIAPP8-20 via the accumulation of helical oligomers, alpha-helix to beta-sheet transition, and formation of beta-barrel intermediates
15. Nucleation of beta-rich oligomers and beta-barrels in the early aggregation of human islet amyloid polypeptide10.1016/j.bbadis.2018.11.021 ↗
16. Medin amyloid may drive arterial aging and disease in the periphery and brain10.1038/s43587-023-00481-3 ↗
17. Functional amyloids from bacterial biofilms - structural properties and interaction partners10.1039/D2SC00645F ↗
18. Functional amyloid--from bacteria to humans10.1016/j.tibs.2007.03.003 ↗
19. Effects of pH on aggregation kinetics of the repeat domain of a functional amyloid, Pmel1710.1073/pnas.1006424107 ↗
20. The peptide hormone glucagon forms amyloid fibrils with two coexisting beta-strand conformations10.1038/s41594-019-0238-6 ↗
21. A buried glutamate in the cross-beta core renders beta-endorphin fibrils reversible10.1039/D1NR05679D ↗
22. The three-dimensional structure of human beta-endorphin amyloid fibrils10.1038/s41594-020-00515-z ↗
23. Structural analysis and architectural principles of the bacterial amyloid curli10.1038/s41467-023-38204-2 ↗
24. A multimethod approach for analyzing FapC fibrillation and determining mass per length10.1016/j.bpj.2021.03.031 ↗
25. Cross-talk between individual phenol-soluble modulins in biofilm enables rapid and efficient amyloid formation10.7554/eLife.59776 ↗
26. Staphylococcus epidermidis strategies to avoid killing by human neutrophils10.1371/journal.ppat.1001133 ↗
27. The biofilm matrix10.1038/nrmicro2415 ↗
28. Staphylococcal biofilms
29. Phenol-soluble modulin alpha and beta display divergent roles in mice with staphylococcal septic arthritis10.1038/s42003-022-03839-2 ↗
30. Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype10.1039/C9MD00044E ↗
31. Structure of biofilm-forming functional amyloid PSMalpha1 from Staphylococcus aureus10.1073/pnas.2406775121 ↗
32. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms10.1371/journal.ppat.1002744 ↗
33. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice10.1172/JCI42520 ↗
34. Role of phenol-soluble modulins in Staphylococcus epidermidis biofilm formation and infection of indwelling medical devices10.1016/j.jmb.2019.03.030 ↗
35. How Staphylococcus aureus biofilms develop their characteristic structure10.1073/pnas.1115006109 ↗
36. Solution structures of phenol-soluble modulins alpha1, alpha3, and beta2, virulence factors from Staphylococcus aureus10.1021/acs.biochem.6b00615 ↗
37. Heparin promotes fibrillation of most phenol-soluble modulin virulence peptides from10.1016/j.jbc.2021.100953 ↗
38. Investigating the lytic activity and structural properties of phenol soluble modulin (PSM) peptide toxins10.1016/j.bbamem.2014.08.026 ↗
39. Modulating kinetics of the amyloid-like aggregation of S. aureus phenol-soluble modulins by changes in pH10.3390/microorganisms9010117 ↗
40. Human fibrinogen inhibits amyloid assembly of most phenol-soluble modulins from Staphylococcus aureus10.1021/acsomega.1c02333 ↗
41. Discrete molecular dynamics: an efficient and versatile simulation method for fine protein characterization10.1021/jp2114576 ↗
42. Ab initio folding of proteins with all-atom discrete molecular dynamics10.1016/j.str.2008.03.013 ↗
43. Discrete molecular dynamics simulations of peptide aggregation10.1103/PhysRevE.69.041908 ↗
44. Solving protein structures using short-distance cross-linking constraints as a guide for discrete molecular dynamics simulations10.1126/sciadv.1700479 ↗
45. Highly accurate protein structure prediction with AlphaFold10.1038/s41586-021-03819-2 ↗
46. United-atom discrete molecular dynamics of proteins using physics-based potentials10.1021/ct8003832 ↗
47. MedusaScore: an accurate force field-based scoring function for virtual drug screening10.1021/ci8001167 ↗
48. Eris: an automated estimator of protein stability10.1038/nmeth0607-466 ↗
49. Ab initio RNA folding by discrete molecular dynamics: from structure prediction to folding mechanisms10.1261/rna.894608 ↗
50. Dissecting the Self-assembly Dynamics of Imperfect Repeats in alpha-Synuclein10.1021/acs.jcim.3c00533 ↗
51. Effective energy functions for protein structure prediction10.1016/S0959-440X(00)00063-4 ↗
52. Molecular insights into the effects of F16L and F19L substitutions on the conformation and aggregation dynamics of human calcitonin10.1021/acs.jcim.4c00553 ↗
53. Identifying weak interdomain interactions that stabilize the supertertiary structure of the N-terminal tandem PDZ domains of PSD-9510.1038/s41467-018-06133-0 ↗
54. Deciphering the influence of Y12L and N17H substitutions on the conformation and oligomerization of human calcitonin10.1039/D3SM01332D ↗
55. Structural perturbation of monomers determines the amyloid aggregation propensity of calcitonin variants10.1021/acs.jcim.2c01202 ↗
56. Molecular insights into the oligomerization dynamics and conformations of amyloidogenic and non-amyloidogenic amylin from discrete molecular dynamics simulations10.1039/D2CP02851D ↗
57. Molecular insights into the self-assembly of block copolymer suckerin polypeptides into nanoconfined beta-sheets
58. Computational insights into the aggregation mechanism and amyloidogenic core of aortic amyloid medin polypeptide10.1016/j.colsurfb.2024.114192 ↗
59. Molecular insights into the surface-catalyzed secondary nucleation of amyloid-beta(40) (Abeta(40)) by the peptide fragment Abeta(16-22)10.1126/sciadv.aav8216 ↗
60. Discrete molecular dynamics approach to the study of disordered and aggregating proteins10.1021/acs.jctc.6b01153 ↗
61. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features10.1002/bip.360221211 ↗
62. Peptide folding: when simulation meets experiment10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-M ↗
63. Computational investigation of coaggregation and cross-seeding between Abeta and hIAPP underpinning the cross-talk in Alzheimer's disease and type 2 diabetes10.1021/acs.jcim.4c00859 ↗
64. Template induced conformational change of amyloid-beta monomer10.1021/jp300389g ↗
65. SEVI inhibits abeta amyloid aggregation by capping the beta-sheet elongation edges10.1021/acs.jcim.3c00414 ↗
66. The chaperone alphaB-crystallin uses different interfaces to capture an amorphous and an amyloid client10.1038/nsmb.3108 ↗
67. alphaB-crystallin chaperone inhibits abeta aggregation by capping the beta-sheet-rich oligomers and fibrils10.1021/acs.jpcb.0c07256 ↗
68. A comprehensive insight into the mechanisms of dopamine in disrupting abeta protofibrils and inhibiting abeta aggregation10.1021/acschemneuro.1c00306 ↗
69. Mitigation of amyloidosis with nanomaterials
70. Anti-biofilm activity of graphene quantum dots via self-assembly with bacterial amyloid proteins10.1021/acsnano.8b09403 ↗